{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,25]],"date-time":"2026-09-25T19:37:23Z","timestamp":1790365043274,"version":"4.1.0"},"reference-count":23,"publisher":"Elsevier BV","issue":"12","license":[{"start":{"date-parts":[[2024,12,1]],"date-time":"2024-12-01T00:00:00Z","timestamp":1733011200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2024,12,1]],"date-time":"2024-12-01T00:00:00Z","timestamp":1733011200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"}],"content-domain":{"domain":["jaci-inpractice.org","clinicalkey.fr","clinicalkey.jp","clinicalkey.com.au","clinicalkey.es","clinicalkey.com","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["The Journal of Allergy and Clinical Immunology: In Practice"],"published-print":{"date-parts":[[2024,12]]},"DOI":"10.1016\/j.jaip.2024.10.006","type":"journal-article","created":{"date-parts":[[2024,10,11]],"date-time":"2024-10-11T00:26:55Z","timestamp":1728606415000},"page":"3274-3282.e2","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":11,"title":["Pharmacokinetic and Pharmacodynamic Profile of Epinephrine Nasal Spray Versus Intramuscular Epinephrine Autoinjector in Healthy Adults"],"prefix":"10.1016","volume":"12","author":[{"given":"Matthew","family":"Greenhawt","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jay","family":"Lieberman","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Michael","family":"Blaiss","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"David I.","family":"Bernstein","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"John","family":"Oppenheimer","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Lawrence","family":"DuBuske","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"David","family":"Fleischer","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"David A.","family":"Dworaczyk","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.jaip.2024.10.006_bib1","doi-asserted-by":"crossref","first-page":"1082","DOI":"10.1016\/j.jaci.2020.01.017","article-title":"Anaphylaxis\u2014a 2020 practice parameter update, systematic review, and Grading of Recommendations, Assessment, Development and Evaluation (GRADE) analysis","volume":"145","author":"Shaker","year":"2020","journal-title":"J\u00a0Allergy Clin Immunol"},{"key":"10.1016\/j.jaip.2024.10.006_bib2","doi-asserted-by":"crossref","first-page":"124","DOI":"10.1016\/j.anai.2023.09.015","article-title":"Anaphylaxis: a 2023 practice parameter update","volume":"132","author":"Golden","year":"2024","journal-title":"Ann Allergy Asthma Immunol"},{"key":"10.1016\/j.jaip.2024.10.006_bib3","series-title":"Goodman & Gilman\u2019s The Pharmacological Basis of Therapeutics","article-title":"Adrenergic agonists and antagonists","author":"Tilley","year":"2023"},{"key":"10.1016\/j.jaip.2024.10.006_bib4","doi-asserted-by":"crossref","first-page":"2321","DOI":"10.1016\/j.jaip.2021.01.038","article-title":"Community use of epinephrine for the treatment of anaphylaxis: a review and meta-analysis","volume":"9","author":"Miles","year":"2021","journal-title":"J\u00a0Allergy Clin Immunol Pract"},{"key":"10.1016\/j.jaip.2024.10.006_bib5","doi-asserted-by":"crossref","first-page":"869","DOI":"10.1111\/j.1365-2222.2011.03743.x","article-title":"Epinephrine auto-injector use in adolescents at risk of anaphylaxis: a qualitative study in Scotland, UK","volume":"41","author":"Gallagher","year":"2011","journal-title":"Clin Exp Allergy"},{"key":"10.1016\/j.jaip.2024.10.006_bib6","doi-asserted-by":"crossref","first-page":"3","DOI":"10.1016\/j.aller.2019.07.009","article-title":"Physicians prescribe adrenaline autoinjectors, do parents use them when needed?","volume":"48","author":"Esenboga","year":"2020","journal-title":"Allergol Immunopathol"},{"key":"10.1016\/j.jaip.2024.10.006_bib7","doi-asserted-by":"crossref","first-page":"1169","DOI":"10.1016\/j.jaip.2017.06.031","article-title":"Fatal anaphylaxis: mortality rate and risk factors","volume":"5","author":"Turner","year":"2017","journal-title":"J\u00a0Allergy Clin Immunol Pract"},{"key":"10.1016\/j.jaip.2024.10.006_bib8","doi-asserted-by":"crossref","first-page":"1016","DOI":"10.1016\/j.jaci.2006.12.622","article-title":"Further fatalities caused by anaphylactic reactions to food, 2001-2006","volume":"119","author":"Bock","year":"2007","journal-title":"J\u00a0Allergy Clin Immunol"},{"key":"10.1016\/j.jaip.2024.10.006_bib9","doi-asserted-by":"crossref","first-page":"57","DOI":"10.1016\/j.jaip.2014.07.004","article-title":"Early treatment of food-induced anaphylaxis with epinephrine is associated with a lower risk of hospitalization","volume":"3","author":"Fleming","year":"2015","journal-title":"J\u00a0Allergy Clin Immunol Pract"},{"key":"10.1016\/j.jaip.2024.10.006_bib10","doi-asserted-by":"crossref","first-page":"186-193.e2","DOI":"10.1016\/j.anai.2024.04.033","article-title":"13.2 mg intranasal epinephrine treatment in congestion shows increased bioavailability without pharmacokinetic and pharmacodynamic correlation","volume":"133","author":"Dworaczyk","year":"2024","journal-title":"Ann Allergy Asthma Immunol"},{"key":"10.1016\/j.jaip.2024.10.006_bib11","article-title":"13.2 mg intranasal epinephrine spray demonstrates comparable pharmacokinetics, pharmacodynamics, and safety to 0.3 mg epinephrine autoinjector","volume":"3","author":"Dworaczyk","year":"2023","journal-title":"J\u00a0Allergy Clin Immunol Global"},{"key":"10.1016\/j.jaip.2024.10.006_bib12","series-title":"Data on file: Bryn Pharma","year":"2023"},{"key":"10.1016\/j.jaip.2024.10.006_bib13","doi-asserted-by":"crossref","DOI":"10.1016\/j.jaci.2021.12.050","article-title":"Subanalysis of an open-label, crossover study to assess the relative bioavailability of self-administered nasal epinephrine compared to administration by trained health personnel in healthy adult subjects","volume":"149","author":"Dworaczyk","year":"2022","journal-title":"J\u00a0Allergy Clin Immunol"},{"key":"10.1016\/j.jaip.2024.10.006_bib14","doi-asserted-by":"crossref","DOI":"10.1016\/j.jaci.2020.12.024","article-title":"5-Period, 5-treatment crossover study to compare the pharmacokinetics of intranasal and intramuscular epinephrine administration in healthy adult participants","volume":"147","author":"Dworaczyk","year":"2021","journal-title":"J\u00a0Allergy Clin Immunol"},{"key":"10.1016\/j.jaip.2024.10.006_bib15","doi-asserted-by":"crossref","DOI":"10.1002\/clt2.12323","article-title":"Adrenaline auto injectors pharmacokinetic\/pharmacodynamic studies and potential consequences for clinical practice","volume":"13","author":"Worm","year":"2023","journal-title":"Clin Transl Allergy"},{"key":"10.1016\/j.jaip.2024.10.006_bib16","doi-asserted-by":"crossref","first-page":"43","DOI":"10.1186\/s13601-018-0230-y","article-title":"A\u00a0qualitative study exploring parents\u2019 experiences with epinephrine use for their child\u2019s anaphylactic reaction","volume":"8","author":"Chooniedass","year":"2018","journal-title":"Clin Transl Allergy"},{"key":"10.1016\/j.jaip.2024.10.006_bib17","doi-asserted-by":"crossref","first-page":"185","DOI":"10.1016\/j.anai.2023.05.033","article-title":"Innovations in the treatment of anaphylaxis: a review of recent data","volume":"131","author":"Lieberman","year":"2023","journal-title":"Ann Allergy Asthma Immunol"},{"key":"10.1016\/j.jaip.2024.10.006_bib18","doi-asserted-by":"crossref","first-page":"508","DOI":"10.1016\/j.anai.2022.10.024","article-title":"Pharmacokinetic and pharmacodynamic comparison of epinephrine, administered intranasally and intramuscularly: an integrated analysis","volume":"130","author":"Tanimoto","year":"2023","journal-title":"Ann Allergy Asthma Immunol"},{"key":"10.1016\/j.jaip.2024.10.006_bib19","doi-asserted-by":"crossref","first-page":"871","DOI":"10.1067\/mai.2001.119409","article-title":"Epinephrine absorption in adults: intramuscular versus subcutaneous injection","volume":"108","author":"Simons","year":"2001","journal-title":"J\u00a0Allergy Clin Immunol"},{"key":"10.1016\/j.jaip.2024.10.006_bib20","doi-asserted-by":"crossref","first-page":"33","DOI":"10.1016\/S0091-6749(98)70190-3","article-title":"Epinephrine absorption in children with a history of anaphylaxis","volume":"101","author":"Simons","year":"1998","journal-title":"J\u00a0Allergy Clin Immunol"},{"key":"10.1016\/j.jaip.2024.10.006_bib21","first-page":"13","article-title":"Auvi-Q--a new epinephrine auto-injector","volume":"55","year":"2013","journal-title":"Med Lett Drugs Ther"},{"key":"10.1016\/j.jaip.2024.10.006_bib22","doi-asserted-by":"crossref","first-page":"539","DOI":"10.1016\/S1081-1206(10)61130-1","article-title":"Adequacy of the epinephrine autoinjector needle length in delivering epinephrine to the intramuscular tissues","volume":"94","author":"Song","year":"2005","journal-title":"Ann Allergy Asthma Immunol"},{"key":"10.1016\/j.jaip.2024.10.006_bib23","doi-asserted-by":"crossref","first-page":"366","DOI":"10.1001\/archinte.1992.00400140110024","article-title":"Cardiovascular responses to phlebotomy and sitting in middle-aged and elderly subjects","volume":"152","author":"Kuchel","year":"1992","journal-title":"Arch Intern Med"}],"container-title":["The Journal of Allergy and Clinical Immunology: In Practice"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S2213219824010547?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S2213219824010547?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2024,12,5]],"date-time":"2024-12-05T09:42:57Z","timestamp":1733391777000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S2213219824010547"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2024,12]]},"references-count":23,"journal-issue":{"issue":"12","published-print":{"date-parts":[[2024,12]]}},"alternative-id":["S2213219824010547"],"URL":"https:\/\/doi.org\/10.1016\/j.jaip.2024.10.006","relation":{},"ISSN":["2213-2198"],"issn-type":[{"value":"2213-2198","type":"print"}],"subject":[],"published":{"date-parts":[[2024,12]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Pharmacokinetic and Pharmacodynamic Profile of Epinephrine Nasal Spray Versus Intramuscular Epinephrine Autoinjector in Healthy Adults","name":"articletitle","label":"Article Title"},{"value":"The Journal of Allergy and Clinical Immunology: In Practice","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.jaip.2024.10.006","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2024 Published by Elsevier Inc. on behalf of the American Academy of Allergy, Asthma & Immunology","name":"copyright","label":"Copyright"}]}}